Information Journal Paper
APA:
Copy. (2019). Intradermal SynCon® Ebola GP DNA Vaccine Is Temperature Stable and Safely Demonstrates Cellular and Humoral Immunogenicity Advantages in Healthy Volunteers. JOURNAL OF INFECTIOUS DISEASES, 220(3), 400-410. SID. https://sid.ir/paper/682553/en
Vancouver:
Copy. Intradermal SynCon® Ebola GP DNA Vaccine Is Temperature Stable and Safely Demonstrates Cellular and Humoral Immunogenicity Advantages in Healthy Volunteers. JOURNAL OF INFECTIOUS DISEASES[Internet]. 2019;220(3):400-410. Available from: https://sid.ir/paper/682553/en
IEEE:
Copy, “Intradermal SynCon® Ebola GP DNA Vaccine Is Temperature Stable and Safely Demonstrates Cellular and Humoral Immunogenicity Advantages in Healthy Volunteers,” JOURNAL OF INFECTIOUS DISEASES, vol. 220, no. 3, pp. 400–410, 2019, [Online]. Available: https://sid.ir/paper/682553/en